Can a virus cause low ejection fraction?
Answers from top 11 papers
More filters
| Papers (11) | Insight |
|---|---|
56 Citations | Our data suggest that the fraction of viruses attached to TEP is highest in areas characterized by a low renewal rate of the water mass and can constitute at times a significant fraction of total virus abundance. |
| The activity in the peak fraction seemed to be structually associated with virus particles. | |
| Nor does it depend on the ejection of saliva in itself; for this alone did not reduce the numbers of aphids that transmitted virus. | |
69 Citations | This study also suggests that metals or metal oxides on sand surfaces can cause significant virus removal under high ionic strength conditions. |
| In addition to immune-mediated latency, it appears that a similar situation can be achieved following infection at low virus titres and/or infection at epithelial sites where the virus life cycle is not properly supported. | |
37 Citations | However, while ejection fraction is statistically associated with mortality, it is only one of multiple factors that impact on mortality. |
29 Citations | The association of mature virus with the large-particle fraction could be explained in part by adsorption of free virus to a component of this fraction; treatment with EDTA released the virus. |
159 Citations | Activation of virus appears to be a very low-frequency event. |
37 Citations | The dangers of focusing on ejection fraction are that many patients whose ejection fractions exceed commonly used cut offs experience sudden death. |
51 Citations | This fraction apparently contains disrupted virus envelopes. |
212 Citations | However, the virus may be the cause of serious diseases, particularly in immunocompromised individuals. |
Related Questions
Heart failure with reduced ejection fraction in the world?5 answersHeart failure with reduced ejection fraction (HFrEF) is a significant concern globally. Studies have shown that the use of sacubitril/valsartan, a medication recommended in the treatment of HFrEF, has been effective in reducing HF-related hospitalizations and cardiovascular mortality. Real-world evidence from Italy indicates that sacubitril/valsartan is rapidly titrated to target doses, with high therapeutic adherence, aligning well with ESC guidelines for HFrEF management. Additionally, the utilization of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitors (RASI/ARNI) and beta-blockers has been associated with lower mortality and morbidity in patients with mildly reduced ejection fraction (HFmrEF). These findings emphasize the importance of guideline-recommended pharmacotherapy in improving outcomes for individuals with HFrEF and HFmrEF.
Can low ejection fraction be temporary?8 answers
Can pneumonia cause low ejection fraction?5 answers
How to improve ejection fraction after Herceptin?5 answers
How to improve ejection fraction by homeopathy?5 answers
How to increase ejection fraction after angioplasty?7 answers